New biobank aims to unlock genetic secrets of bipolar disorder

NCT ID NCT07173842

Not yet recruiting Knowledge-focused Sponsor: Selçuk State Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will create a large biobank of blood samples and detailed health information from 1,000 people with bipolar disorder in Turkey. Researchers will collect DNA and clinical data to better understand the condition and find genetic clues that could improve diagnosis and treatment in the future. No drugs or treatments are tested; the goal is to build a resource for ongoing research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this biobank could help researchers discover genetic markers linked to bipolar disorder, potentially leading to better diagnosis and personalized treatments in the future.
What could go wrong: This is an early-stage observational study that does not test any treatment. It only collects data and samples for future research, so there is no direct benefit to participants, and the hoped-for discoveries may take years or may not happen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder mood disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIPOLAR DISORDER

Contacts and locations

Locations

Selçuk University Faculty of Medicine, Department of Psychiatry / NeuroPsyBiT-RTSGD Consortium

Konya, Konya, 42130, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.